Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 28, 2012

View Archived Issues

CAP-7.1 evaluated in patients with solid tumors

Sarepta Therapeutics enters collaboration for DMD drug

miRNA-768-3p is downregulated in human GBM cells

Autophagy-related proteins correlate with acute myelogenous leukemia prognosis

Lilly Japan set to launch Zyprexa intramuscular injection

EMA accepts for review MAAs for vintafolide and etarfolatide

Novel IL-4/IL-13 binding proteins patented by Janssen Biotech and Molecular Partners

Unigene and Tarix enter licensing agreement for TXA-127

FDA clears Avaxia Biologics' IND for AVX-470

Amakem patents new ROCK-II inhibitors

ChemoCentryx begins phase I trial of CCX-872

Panacela Labs signs contract with Russian Ministry of Industry and Trade

Novel agents for the treatment of myocardial infarction disclosed by Grindeks

MMRF partners with the Department of Veterans Affairs

Gilead Sciences reports results from phase III sofosbuvir trial

Johns Hopkins researchers develop pan-malaria transmission-blocking vaccine

Phase III pimavanserin study meets primary endpoints

Japanese scientists present new humanized monoclonal antibodies

Ruga presents next-generation B-raf V600E inhibitors

Amgen synthesizes novel protein kinase inhibitors

Phase II study of ProHema for hematologic malignancies begins

U.K.'s NICE selects ThromboGenics' Jetrea for single technology appraisal

Trial of Bayer's investigational hemophilia treatment completes recruitment of first cohort

European Commission approves Viread for two new indications

Forest Laboratories submits NDA for cariprazine in two mental health disorders

Almirall reports novel PI3Kdelta inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...